Thursday, February 10, 2005

Medicolegal Considerations in the Treatment of Psychosis With Second-Generation Antipsychotics Psychiatric Times article - "Are the metabolic side effects of the atypical antipsychotics fueling the next round of malpractice suits being filed against psychiatrists? Guidelines are being created, but how can clinicians protect themselves and their patients, while continuing to give their patients the best care available?"  
  

Maintenance and Long-Term Treatment Issues in Selected Special Populations: Schizophrenia  CME unit at Psychiatric Times - "What special issues do psychiatrists face when treating women, children and adolescents, and elderly people with schizophrenia? Are there recommendations for care and monitoring strategies to maintain patients on effective, long-term treatment regimens? "  
  

DHEA May Be Effective for Midlife-Onset Minor and Major Depression A new Medscape Medical News CME unit - "Dehydroepiandrosterone (DHEA) can be effective for midlife-onset minor and major depression, according to the results of a placebo-controlled, randomized trial published in the February issue of the Archives of General Psychiatry." [Viewing Medscape resources requires registration, which is free].